Dr Reddy’s gets 2 observations from USFDA for New York API plant
Dr. Reddy's Laboratories announced that the USFDA issued a Form 483 with two observations after a GMP inspection of its API manufacturing facility in Middleburgh, New York. The inspection, conducted between May 12-16, 2025, identified potential violations of the Food Drug and Cosmetic Act.
A return to ‘the Portlandia economy’? Not without hospitality jobs, city economists say – OregonLive.com
A return to ‘the Portlandia economy’? Not without hospitality jobs, city economists say O…
